- $82.20m
- $90.34m
- $135.00m
- 61
- 55
- 70
- 66
Annual income statement for GAN, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 35.2 | 124 | 142 | 129 | 135 |
| Cost of Revenue | |||||
| Gross Profit | 24.7 | 82.8 | 99.9 | 90.7 | 94.6 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Depreciation and Amortization | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 54.6 | 155 | 334 | 160 | 139 |
| Operating Profit | -19.5 | -31.2 | -193 | -30.3 | -3.6 |
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -19.9 | -30.8 | -194 | -34.3 | -8.23 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -20.2 | -30.6 | -197 | -34.4 | -7.96 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -20.2 | -30.6 | -197 | -34.4 | -7.96 |
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -20.2 | -30.6 | -197 | -34.4 | -7.96 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -0.749 | -0.674 | -2.09 | -0.793 | -0.163 |